Degenerative Hip Joint Disease
3
1
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
4 treatments under study, led by Rthra Group
Related Conditions
Often studied with 11 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
33.3%
1 terminated out of 3 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip System
Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Revision Total Hip Replacement Arthroplasty and Hematologic Variables
Research Network
Common Treatments
- Rthra Group1
- Or3o Dual Mobility System1
- Total Hip Arthroplasty Primary Or Revision1
- Conventional1
Active Sponsors
- Dedienne Sante S.A.S.1
- Smith & Nephew Medical (Shanghai) Ltd1
- Seoul National University Bundang Hospital1
- EVAMED1
Top Investigators
First Affiliated Hospital of Xinjiang Medical University
Seoul National University Bundang Hospital
Clinique Mutualiste Catalane
Related Conditions
- Femoral Neck Fractures2
- Posttraumatic Osteoarthritis1
- Avascular Necrosis Of Hip1
- Avascular Necrosis Of Femoral Head1
- Hip Arthritis1